Hemoglobin level and survival in cervical cancer with chemoradiotherapy at high altitude, 2020–2022

There is no difference between altitude and survival, but the difference in pre-treatment Hb level was a prognostic indicator of survival, with a Hb level of ≤8.9 g/dL being the worst prognosis.

Authors

Institutions

Publication Details

Journal
ecancermedicalscience
Published
2024-09-13
DOI
https://doi.org/10.3332/ecancer.2024.1767
Primary Topic
High Altitude and Hypoxia
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hemoglobin level and survival in cervical cancer with chemoradiotherapy at high altitude, 2020–2022

José F. Robles-Díaz
ecancermedicalscience
High Altitude and Hypoxia
article

Hemoglobin level and survival in cervical cancer with chemoradiotherapy at high altitude, 2020–2022

José F. Robles-Díaz
article en

Abstract

There is no difference between altitude and survival, but the difference in pre-treatment Hb level was a prognostic indicator of survival, with a Hb level of ≤8.9 g/dL being the worst prognosis.

ecancermedicalscienceVol. 18
Twitter (United States) (US)
Good health and well-being
Openalex Percentile: Top 83%
High Altitude and Hypoxia
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Hemoglobin level and survival in cervical cancer with chemoradiotherapy at high altitude, 2020–2022 — José F. Robles-Díaz · ecancermedicalscience (2024) | TGRS Research Map | TGRS